Fund Holdings — Prosight Management, LP

Total Portfolio Value:
$410.06M
Total Bought:
$156.95M
Total Sold:
$55.61M
Net Transaction:
+$101.34M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Lakefront Biotherapeutics NVADR(LKFT)1,314,8981,773,649+458,751$33.03M$49.64M12.11%+$16.61M
UnitedHealth Group Incorporated(UNH)0110,000+110,000$0$34.32M8.37%+$34.32M
MeiraGTx Holdings plc(MGTX)3,691,5464,587,423+895,877$25.03M$29.91M7.29%+$4.88M
ADC Therapeutics SASHS(ADCT)9,543,00410,467,771+924,767$13.46M$28.05M6.84%+$14.60M
BridgeBio Pharma, Inc.(BBIO)610,000472,687-137,313$21.09M$20.41M4.98%-$677.1K
Roivant Sciences Ltd.SHS(ROIV)1,826,1631,808,539-17,624$18.43M$20.38M4.97%+$1.96M
Amicus Therapeutics Inc
COM
1,379,3833,480,044+2,100,661$11.26M$19.94M4.86%+$8.68M
Janux Therapeutics, Inc.(JANX)689,901853,904+164,003$18.63M$19.73M4.81%+$1.10M
Kura Oncology, Inc.(KURA)2,078,3153,181,184+1,102,869$13.72M$18.36M4.48%+$4.64M
Zymeworks Inc.(ZYME)957,2291,309,904+352,675$11.40M$16.44M4.01%+$5.04M
ICON Public Limited CompanySHS(ICLR)60,09998,558+38,459$10.52M$14.34M3.50%+$3.82M
argenx SEADR(ARGX)13,70022,000+8,300$8.11M$12.13M2.96%+$4.02M
Mirum Pharmaceuticals, Inc.(MIRM)343,326200,000-143,326$15.47M$10.18M2.48%-$5.29M
Syndax Pharmaceuticals, Inc.(SNDX)609,2521,079,673+470,421$7.48M$10.11M2.47%+$2.63M
Tectonic Therapeutic, Inc.(TECX)398,885442,056+43,171$7.06M$8.78M2.14%+$1.72M
Crinetics Pharmaceuticals In0298,123+298,123$0$8.57M2.09%+$8.57M
CytomX Therapeutics, Inc.(CTMX)3,930,0083,517,113-412,895$2.50M$7.98M1.95%+$5.49M
Immunovant, Inc.(IMVT)360,000479,400+119,400$6.15M$7.67M1.87%+$1.52M
Biohaven Ltd.(BHVN)100,000539,071+439,071$2.40M$7.61M1.85%+$5.20M
Concentra Group Holdings Parent, Inc.(CON)0312,105+312,105$0$6.42M1.57%+$6.42M
LivaNova PLCSHS(LIVN)127,300140,000+12,700$5.00M$6.30M1.54%+$1.30M
DexCom, Inc.(DXCM)070,000+70,000$0$6.11M1.49%+$6.11M
CareDx, Inc.(CDNA)136,593302,808+166,215$2.42M$5.92M1.44%+$3.49M
Select Med Hldgs Corp0353,820+353,820$0$5.37M1.31%+$5.37M
Shattuck Labs, Inc.(STTK)6,638,9356,638,9350$6.31M$5.26M1.28%-$1.05M
Acadia Healthcare Company, Inc.(ACHC)290,000211,816-78,184$8.79M$4.81M1.17%-$3.99M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)575,136579,893+4,757$3.05M$4.00M0.98%+$947.3K
Rocket Pharmaceuticals, Inc.(RCKT)1,480,0001,580,588+100,588$9.87M$3.87M0.94%-$6.00M
Sight Sciences, Inc.(SGHT)969,287871,687-97,600$2.33M$3.60M0.88%+$1.27M
Axogen, Inc.(AXGN)0282,809+282,809$0$3.07M0.75%+$3.07M
Lantheus Holdings, Inc.(LNTH)034,576+34,576$0$2.83M0.69%+$2.83M
Mural Oncology Pub Ltd Co422,743900,000+477,257$532.7K$2.22M0.54%+$1.69M
Prothena Corp PlcSHS
SHS
408,122267,800-140,322$5.05M$1.63M0.40%-$3.42M
OrthoPediatrics Corp.(KIDS)073,647+73,647$0$1.58M0.39%+$1.58M
Pliant Therapeutics, Inc.(PLRX)334,263837,400+503,137$451.3K$971.4K0.24%+$520.1K
Rein Therapeutics Inc.(RNTX)430,000427,919-2,081$761.1K$599.1K0.15%-$162.0K
OnKure Therapeutics, Inc.CL A(OKUR)186,570159,692-26,878$802.3K$381.7K0.09%-$420.6K
Erasca, Inc.(ERAS)947,110240,295-706,815$1.30M$305.2K0.07%-$992.4K
PepGen Inc.(PEPG)0243,980+243,980$0$270.8K0.07%+$270.8K
AbCellera Biologics Inc.(ABCL)2,815,6520-2,815,652$6.28M$0—-$6.28M
Addus Homecare Corp24,0450-24,045$2.38M$0—-$2.38M
Blueprint Medicines Corp36,5120-36,512$3.23M$0—-$3.23M
Haemonetics Corporation(HAE)65,4000-65,400$4.16M$0—-$4.16M
Immunome, Inc.(IMNM)23,6180-23,618$158.9K$0—-$158.9K
Intuitive Surgical, Inc.(ISRG)14,0000-14,000$6.93M$0—-$6.93M
Schrödinger, Inc.(SDGR)385,0000-385,000$7.60M$0—-$7.60M
Spyre Therapeutics, Inc.(SYRE)74,9210-74,921$1.21M$0—-$1.21M
Page 1 of 1
Prosight Management, LP — 13F Holdings — Q2 2025 | TickerTrail